N | RR (95% CI) | I2 (%) | P value | |
---|---|---|---|---|
Total cardiovascular disease | ||||
Sex | ||||
Male | 3 | 0.98 (0.89–1.08) | 0.0 | 0.959 |
Female | 4 | 0.94 (0.73–1.13) | 79.9 | |
Case | ||||
Mortality | 8 | 0.93 (0.82–1.05) | 63.9 | 0.255 |
Incidence | 3 | 1.10 (0.82–1.48) | 82.7 | |
Location | ||||
United States | 3 | 1.07 (0.78–1.48) | 86.2 | 0.606 |
Europe | 2 | 0.93 (0.81–1.05) | 0.0 | |
Asia | 5 | 0.99 (0.83–1.17) | 70.8 | |
Coronary heart disease | ||||
Sex | ||||
Male | 3 | 0.89 (0.81–0.99) | 3.5 | 0.409 |
Female | 4 | 0.95 (0.83–1.09) | 51.8 | |
Case | ||||
Mortality | 5 | 0.81 (0.69–0.95) | 36.3 | 0.105 |
Incidence | 3 | 0.97 (0.90–1.05) | 12.7 | |
Location | ||||
United States | 3 | 0.95 (0.88–1.03) | 27.6 | 0.439 |
Asia | 4 | 0.84 (0.68–1.03) | 42 | |
Stroke | ||||
Subtype | ||||
Ischemic | 10 | 0.93 (0.88–0.98) | 28.9 | 0.285 |
Hemorrhagic | 9 | 0.97 (0.88–1.07) | 29.0 | |
Sex | ||||
Male | 8 | 0.93 (0.89–0.98) | 0.9 | 0.884 |
Female | 7 | 0.94 (0.87–1.02) | 37.2 | |
Case | ||||
Mortality | 4 | 1.07 (0.90–1.28) | 45.0 | 0.028 |
Incidence | 13 | 0.92 (0.89–0.95) | 0.0 | |
Location | ||||
United states | 6 | 0.91 (0.87–0.95) | 0.0 | 0.140 |
Europe | 6 | 0.93 (0.89–0.98) | 0.0 | |
Asia | 5 | 1.00 (0.80–1.23) | 63.5 | |
Type 2 diabetes | ||||
Sex | ||||
Male | 5 | 0.85 (0.79–0.93) | 48.3 | 0.381 |
Female | 9 | 0.81 (0.75–0.87) | 65.8 | |
Location | ||||
United States | 11 | 0.81 (0.77–0.86) | 63.2 | 0.968 |
Asia | 9 | 0.79 (0.69–0.90) | 62.4 | |
All-cause mortality | ||||
Sex | ||||
Male | 2 | 0.91 (0.84–0.98) | 0.0 | 0.745 |
Female | 3 | 0.88 (0.68–1.14) | 62.5 | |
Location | ||||
United States | 2 | 0.77 (0.58–1.04) | 46.9 | 0.134 |
Europe | 2 | 0.83 (0.66–1.06) | 72.6 | |
Asia | 3 | 0.98 (0.87–1.11) | 51.5 |